« Previous Next » Surgery
Volume 148, Issue 3 , Pages 499-509 , September 2010

Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury

Mark R. Hemmila, MD
- Department of Surgery, University of Michigan Medical School, Ann Arbor, MI
- Reprint requests: Mark R. Hemmila, MD, Trauma Burn Center, University of Michigan Health System, 1B407 University Hospital, 1500 E. Medical Center Drive, SPC 5033, Ann Arbor, MI 48109-5033.
Aladdein Mattar, MD
- Department of Surgery, University of Michigan Medical School, Ann Arbor, MI
Michael A. Taddonio, BS
- Department of Surgery, University of Michigan Medical School, Ann Arbor, MI
Saman Arbabi, MD
- Department of Surgery, University of Washington Medical School, Seattle, WA
Tarek Hamouda, MD, PhD
- NanoBio Corporation, Ann Arbor, MI
Peter A. Ward, MD
- Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
Stewart C. Wang, MD, PhD
- Department of Surgery, University of Michigan Medical School, Ann Arbor, MI
James R. Baker Jr., MD
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI
- NanoBio Corporation, Ann Arbor, MI

,Accepted 8 January 2010.

To access this article, please choose from the options below

Supported in part by research grants from the National Institutes of Health (K08-GM078610 to M.R.H.) and joint support from the American College of Surgeons and the American Association for the Surgery of Trauma (to M.R.H.)

James R. Baker Jr, MD, is the Executive Chairman and Chief Executive Officer of NanoBio Corporation, Ann Arbor, MI; Tarek Hamouda, MD, PhD, is the Director of Vaccine Research for NanoBio Corporation, Ann Arbor, MI.

PII: S0039-6060(10)00007-3

doi: 10.1016/j.surg.2010.01.001

« Previous Next » Surgery
Volume 148, Issue 3 , Pages 499-509 , September 2010